Day 2, Sat 5 March 2016

08:00 - 09:30

Free Paper Presentations (10 min each)

Chairpersons: Saeb Hammoudi (Jordan), Hamad Al-Bahili (KSA), Amr Abdelaal (Egypt), Walid El-Moghazy (Qatar)

• Prognosis And Results After Resection Of Very Large (>10 Cm) Hepatocellular Carcinoma.
  Sameer Smadi (Jordan)
• Role Of Laparoscopy In Changing The Management Of Hepatocellular Carcinoma
  Mohamed Seleem (Egypt)
• Pattern Of Hepatocellular Carcinoma Recurrence Following Living Donor Liver Transplantation
  Tarek Ibrahim (Egypt)
• Low Utility Of FDG-PET CT In Patients With Hepatocellular Carcinoma Before Liver Transplantation
  Hussien Elsiesy (KSA)
• Therapeutic Response Assessment And Outcome Of Radiofrequency Ablation For Hepatocellular Carcinoma: Correlation With Histopathological Pattern
  Asmaa Gomaa (Egypt)
• Y-90 Radioembolization Of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
  Mohamed Abdelmaksoud (Egypt)
• Laparoscopic Lt. Lateral Bisegmentectomy For HCC: Moving From Peripheral To Anatomical, NLI Experience (Video Presenation)
  Hossam Soliman (Egypt)

09:30 - 10:00

State-of-the-art Lecture - Joint session with ILCA
Chairpersons: Jonas Feilchenfeldt (Qatar), Sarbar Napaki (Qatar)

Molecular targeted therapies in advanced HCC
Josep Llovet (Spain/USA)

10:00 - 10:30

Coffee Break

10:30 - 11:30

Plenary III: (30 minutes each) Joint session with ILCA
Chairpersons: Noora Al-Hammadi (Qatar), Hamad Al-Suhaibani (KSA), Yasser Khafaga (KSA)

• Trans-Arterial Therapies for Hepatocellular Carcinoma
  Riad Salem (USA)
• Role of external beam radiation therapy in management of hepatocellular carcinoma
  Laura Dawson (Canada)
  

11:30 - 12:00

State-of-the-art Lecture
Chairpersons: Muna Albakri (Qatar), Hussain Elsiesy (KSA), Yasser Kamel (Qatar)
Impact of New Antiviral Therapies on Management Strategies for Hepatocellular
Massimo Colombo (Italy)

12:00 - 12:30

Coffee Break

12:30 - 14:00

Plenary IV: (20 minutes each)
Chairpersons: Alexander Knuth (Qatar), Ibrahim Al-Hijji (Qatar), Faisal Abaalkail (KSA)

• Diagnostic challenges of Hepatocellular Carcinoma and Mimicking Lesions
  Ahmed Mahfouz (Qatar) 
• Combined Interventional Radiological Management of Unresectable HCC
  Sameh Abdel Wahab  (Egypt)
  
• Combining Sorafenib with Other Treatment Modalities in Hepatocellular Carcinoma
  Jonas Feilchenfeldt (Qatar)
• Is There a Place for Immunotherapy in Hepatocellular Carcinoma?
  Kakil Rassul (Qatar)
  

State-of-the-art Lecture
Chairpersons: Mahmoud El-Meteini (Egypt), Faisal Malmstrom (Qatar)

Liver Resection for Hepatocellular Carcinoma in Cirrhosis
Jacques Belghiti (France)

14:30 - 15:30

Lunch Break

15:30 - 17:00

Plenary V: (20 minutes each)
Chairpersons: Mohamed Abunada (Qatar), Mohammed Al-Saghier (KSA), Reyadh Mohsen (Qatar)

• Living Donor Liver Transplantation for HCC beyond all criteria: Outcome analysis
  Mahmoud El-Meteini (Egypt),
• The Role of Cytoreductive Surgery and HIPEC in advanced Hepatocellular Carcinoma
  Tarek Amin (KSA)
• Ruptured Hepatocellular Carcinoma: Why, When, and How to Manage?
  Ahmed Zarour (Qatar)
  
• Palliative Care For Patients With Hepatocellular Carcinoma
  Ayman Allam (Qatar)
  

17:00 - 17:30

Coffee Break

17:30 - 18:00

State-of-the-art Lecture
Chairpersons: Jacques Belghiti (France), Ahmed Elaffandi (Qatar)

Transplantation vs. Resection for Hepatocellular Carcinoma
Pierre-Alan Clavien (Switzerland)

18:00

Awarding Ceremony and Closing Remarks